MC2 Therapeutics A/S: Financial statements 2021
CVR: 29526346
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
MC2 Therapeutics A/S (CVR 29526346) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 27,734,440 and a net result of DKK -25,222,958 compared with DKK -86,940,654 the year before. That is an increase of 74% compared with the year before. Equity in the 2021 report amounted to DKK -21,097,586. The company had 19 employees in the financial year.
- Gross Profit
- DKK 27,734,440
- Profit/Loss
- DKK -25,222,958
- Equity
- DKK -21,097,586
- Total Assets
- DKK 51,602,510
- Employees
- 19
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 27.7M | -25.2M | -21.1M | 19 |
| 2020 | - | 15.9M | -86.9M | 13.9M | - |
| 2019 | - | 13.7M | -81.4M | 65.8M | 11 |
| 2018 | - | 13.3M | -110.1M | 62.3M | 10 |
| 2017 | - | 10.3M | -79.1M | 30.9M | 8 |
Official annual report
Find more companies like MC2 Therapeutics A/S
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
MC2 Therapeutics A/S has published its annual report for 2020. Gross profit came to DKK 15,938,167, and the net result was DKK -86,940,654.
About MC2 Therapeutics A/S
MC2 Therapeutics A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2006. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named MC2 Therapeutics ApS and MC2 BIOTEK ApS. The management consists of Trine Ahlgreen. The board consists of Mads Jørgen Nøhr Clausen (chair), Anders Dahlgaard Hove, John Sørensen Haurum and Tomas Dahl Mikkelsen. The company is owned by Alsmark Invest II ApS, MC2 HOLDING ApS and Selskabet af 4. april 2023 ApS. The company has 8 employees (2026). In 2025, the company reported a gross profit of DKK 22,248,504 and a net result of DKK -7,816,954 compared with DKK -53,006,931 the year before. Equity in the 2025 report amounted to DKK -224,478,927.